After successful acceleration, we say goodbye to our project OxyPrem. We wish the dedicated team continued success on their journey.
A world premiere
Wyss Zurich project Liver4Life achieves breakthrough in transplant medicine
German Innovation Award 2022
Wyss Zurich project hemotune is winner of the German Innovation Award 2022 in the category Medical Technologies
Wyss Zurich receives further donation of around CHF 100 million from Swiss entrepreneur and philanthopist Dr. h.c. mult. Hansjörg Wyss.
New project launched at Wyss Zurich
A very warm welcome to the Recolony project team at Wyss Zurich. Recolony is developing a bacteria-based cancer therapy.
we are hiring
Take a look at our current job openings.
The Wyss Zurich Workshop
Wyss Zurich hosts its very first Wyss Zurich Workshop on Tuesday, May 24, 2022. Apply now.
The Wyss Zurich project denovoSkin has evolved from a promising research project into the successful start-up CUTISS. After five years of support from Wyss Zurich, we wish the team continued success.
Sevensense raises a US$7.7M Series A
TOP 100 STARTUP AWARD 2021
Numerous Wyss Zurich projects under the TOP 100 Startups 2021
New Project Video
See what our project Phire is working on in the new video.
2021 Wyss Zurich Annual Event
Impressions of the sixth Wyss Zurich Annual Event at the new extension to the Kunsthaus Zurich.
The video of our project MUVON is out. Take a look.
Seervision raises 3.7M CHF to accelerate market expansion.
The video of our project Nanoflex is out. Take a look.
Wyss Zurich projects are fortunate to work in one of the most exciting places in Europe – with excellent facilities, short working distances, and close collaboration with world-leading experts.
Wyss Zurich welcomes the news that Novartis has signed a cooperation agreement and an option to acquire Cellerys
hemotune on Forbes list 30 "Spin-offs To Watch 2021"
THE WYSS ZURICH ALUMNI PROJECT
ANYbotics raises CHF 20 million series A funding
The Wyss Zurich Heart
The artwork concept by PATHOS is based on the initial idea of Wyss Zurich – the union of the university's medical aspects combined with ETH's robotics developments and research.
Partial ISO 13485 QMS
Wyss Zurich implements product development processes in alignment with ISO 13485 requirements to support and accelerate medical device projects
Wyss Zurich brings together the excellence of ETH Zurich and the University of Zurich in the emerging fields of Regenerative Medicine and Robotics
Enhancing the regeneration of the injured central nervous system
Restoring immune balance in sepsis
Tissue-engineered human matrices to repair and regenerate the heart
Regeneration of the human liver outside of the body
Regain control through personalized muscle regeneration
Advancing medical robotic interventions
Antibody-enabled blood stem cell transplantation
Bacteria-based cancer therapy
Gene therapy solutions for patients with severe inherited diseases
Advanced flying robots to revolutionize work at height
Empower future pioneers
Poetic Animatronics Through Hands-On Systems
Enhancing the interaction skills and mobility of robots
Personalized skin grafts to treat skin defects
Establishing immune tolerance in Multiple Sclerosis
Improving the biocompatibility of implantable medical devices
Brain oxygen measurement for preterm infants
Train a Robot. Learn Science.
Camera automation software for effortless video production
Visual navigation for the next generation of service robots
A modular system of application-specific prosthetic hands
Flying robots that take-off and land like helicopters, but fly like planes
Replicating the human visual perception for robots
Recolony was nominated to participate in the Meet the Venture Leaders Biotech 2022 event
Nanoflex has developed a novel catheter that is magnetically steerable and used for rapid and safe stroke treatment
Voliro and Constellation Clearsight to bring highly maneuverable drone inspections to U.S. utilities market
A world premiere: for the first time, a human liver was treated in a machine and then successfully transplanted
hemotune is winner of the German Innovation Award 2022 in the category Medical Technologies
Successful Wyss Zurich model receives further donation of around CHF 100 million
Gallatin Award - Swiss Science Celebrates Hansjörg Wyss
Wyss Zurich participates in the Day of Clinical Research at USZ
#SUD22: Wyss Zurich at Startup Days in Berne on May 19, 2022
Badische Neueste Nachrichten - World-renowned robotics researcher Roland Siegwart honored with Ernst-Blickle-Award
hemotune raises CHF 7.25 million Series B1 funding for the development of their disruptive blood purification platform
Scientific Board members are leaders in the field of Regenerative Medicine and Robotics. They are in charge of reviewing full project applications (first-round assessment) on the basis of Wyss Zurich Qualification Criteria, notably scientific excellence.
The state-of-the-art technology platforms support the advancement of the Wyss Zurich projects.
Wyss Zurich Translational Center
ETH Zurich / University of Zurich
Weinbergstrasse 35, WEH